Gluconorm-G 3 Forte Tablet PR is a combination oral antidiabetic medication containing Glimepiride 3 mg and Metformin 1000 mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production, enhancing peripheral glucose uptake, and improving insulin sensitivity. The combination offers complementary mechanisms, providing effective control of blood glucose levels in patients inadequately controlled by diet, exercise, or monotherapy. Gluconorm-G 3 Forte Tablet PR is designed for prolonged release, ensuring sustained plasma concentration and improved patient compliance through reduced dosing frequency. It is recommended to be administered with meals to minimize gastrointestinal side effects commonly associated with Metformin, such as nausea and diarrhea. Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to lactic acidosis. Regular monitoring of blood glucose, renal function, and hematologic parameters is essential during therapy. This combination should be used as part of a comprehensive diabetes management plan including diet, exercise, and weight control. Gluconorm-G 3 Forte Tablet PR is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or hypersensitivity to its components.